News

Fabian’s oxygen saturation in his blood had fallen to less than 50%, dangerously below the normal range of 95% to 100%.

Fabian looked fine and his breathing seemed normal, but something was clearly wrong. He was diagnosed with D-Transposition of the Great Arteries, a major heart defect that limits blood flow from lungs to the body.

Atrility Medical, the innovative health-care start-up company launched by UW Health pediatric cardiologist Nick Von Bergen, MD, has reached several notable milestones during the first half of 2021.

Atrility Medical LLC, which developed a device to better monitor the heart after surgery, was the grand prize winner of the 18th annual Wisconsin Governor’s Business Plan Contest, according to a June 3 announcement by the Wisconsin Technology Council.

Atrility Medical today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the AtriAmp™ Device, which facilitates atrial electrogram monitoring and treatment of atrial arrhythmias in post-operative settings.

An article by the Isthmus Project, a subsidiary of UW Health, about the development of the AtriAmp and founding of Atrility Medical.

An article from 2019 on the University of Wisconsin - Madison website highlighting the early development effort for the AtriAmp device and Dr. Von Bergen’s motivations for the invention.